<p>At 12 weeks post-boost immunization, immune and PBS mock control mice (n = 5 per group) were i.n. challenged with 2x10<sup>6</sup> PFU RSV A2. Naïve: unimmunized mice without RSV infection, PBS: PBS mock control mice with RSV infection, live RSV: live RSV re-infection mice after RSV infection, FI-RSV-A: FI-RSV-A immune mice after RSV challenge, FI-RSV: FI-RSV immune mice after RSV challenge. (A) Body weight changes in naïve and prior live RSV reinfected mice after RSV challenge. (B) Body weight changes in naïve, FI-RSV-A, and FI-RSV mice after RSV challenge. (C) RSV titers in lungs. After 5 d.p.c., individual lungs were collected and virus titers were determined. Results are presented as mean ± SEM (n = 5). Statistical significances were...
<p>BALB/c mice and IL-10<sup>−/−</sup> mice were infected with 10<sup>6</sup> PFU RSV i.n. (day 0). ...
<p>Mice were (mock-)vaccinated three times either intranasally with BLP-F (○) or PBS (▪) or intramus...
<p>A low dose of alum (5 μg) adjuvant effects was compared with FI-RSV-A (with 20 μg alum) after FI-...
<p>Groups of BALB/c mice were vaccinated with nanoparticle diluted in PBS to yield 50 µg of designed...
<p>(A) FI-mock- and FI-RSV-vaccinated mice were monitored daily for airway obstruction using a whole...
<p>BALB/c mice were immunized with FI-RSV and treated with either IgG or anti-TNF-α neutralization a...
Vaccinated and naïve mice (n = 5) were intranasally challenged with RSV A2 (5×105 PFU) at 3 weeks af...
<p>Balb/c mice were immunized according to <a href="http://www.plosone.org/article/info:doi/10.1371/...
<p>Lung viral titers were determined from mice immunized with V1 or V5 VLPs and from FI-RSV immunize...
<p>Mice were i.m. vaccinated with formalin inactivated RSV A2, rested for at four weeks and i.n chal...
<p>BALB/c mice were infected with 10<sup>6</sup> PFU RSV i.n. (day 0). Where indicated, mice were in...
<p>Mice were vaccinated with 50 µg of RSV G nanoparticles, 10 µg of purified G protein emulsified 1:...
<p>(A) Total BAL cell counts in the lungs of mice i.m. vaccinated with FI-RSV A2 and live RSV A2 ch...
<p>RSV-infected mice were treated with suboptimal doses of either anti-G mAb (130-6D, 150 µg/mouse) ...
<p>Mice were i.m. vaccinated with formalin inactivated RSV A2 (FI-A2) and then s.c. vaccinated with ...
<p>BALB/c mice and IL-10<sup>−/−</sup> mice were infected with 10<sup>6</sup> PFU RSV i.n. (day 0). ...
<p>Mice were (mock-)vaccinated three times either intranasally with BLP-F (○) or PBS (▪) or intramus...
<p>A low dose of alum (5 μg) adjuvant effects was compared with FI-RSV-A (with 20 μg alum) after FI-...
<p>Groups of BALB/c mice were vaccinated with nanoparticle diluted in PBS to yield 50 µg of designed...
<p>(A) FI-mock- and FI-RSV-vaccinated mice were monitored daily for airway obstruction using a whole...
<p>BALB/c mice were immunized with FI-RSV and treated with either IgG or anti-TNF-α neutralization a...
Vaccinated and naïve mice (n = 5) were intranasally challenged with RSV A2 (5×105 PFU) at 3 weeks af...
<p>Balb/c mice were immunized according to <a href="http://www.plosone.org/article/info:doi/10.1371/...
<p>Lung viral titers were determined from mice immunized with V1 or V5 VLPs and from FI-RSV immunize...
<p>Mice were i.m. vaccinated with formalin inactivated RSV A2, rested for at four weeks and i.n chal...
<p>BALB/c mice were infected with 10<sup>6</sup> PFU RSV i.n. (day 0). Where indicated, mice were in...
<p>Mice were vaccinated with 50 µg of RSV G nanoparticles, 10 µg of purified G protein emulsified 1:...
<p>(A) Total BAL cell counts in the lungs of mice i.m. vaccinated with FI-RSV A2 and live RSV A2 ch...
<p>RSV-infected mice were treated with suboptimal doses of either anti-G mAb (130-6D, 150 µg/mouse) ...
<p>Mice were i.m. vaccinated with formalin inactivated RSV A2 (FI-A2) and then s.c. vaccinated with ...
<p>BALB/c mice and IL-10<sup>−/−</sup> mice were infected with 10<sup>6</sup> PFU RSV i.n. (day 0). ...
<p>Mice were (mock-)vaccinated three times either intranasally with BLP-F (○) or PBS (▪) or intramus...
<p>A low dose of alum (5 μg) adjuvant effects was compared with FI-RSV-A (with 20 μg alum) after FI-...